Recent admission by AstraZeneca that its Covid vaccines Covishield and Vaxzevria might in very rare instances cause Thrombosis with Thrombocytopenia Syndrome has set the panic waves in the

AstraZeneca recently acknowledged before a UK court that its Covid vaccine can lead to a rare blood clot side effect known as Thrombosis with Thrombocytopenia Syndrome. There have

Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 million.

AstraZeneca (AZ) has admitted its Covid vaccine may cause Thrombosis with Thrombocytopenia Syndrome (TTS). Know all about the rare side effect.

British pharmaceutical giant AstraZeneca has acknowledged that its Covid vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS)

AstraZeneca has always specified the rare side-effects of their COVID-19 vaccine called Covishield which was manufactured by Serum Institute of India. These risks were in a public domain since 2021 and are being re-shared amid elections.